Peer-reviewed veterinary case report
Duodenal-Jejunal Bypass Maintains Gut Permeability by Suppressing Gut Inflammation.
- Journal:
- Obesity surgery
- Year:
- 2019
- Authors:
- Kashihara, Hideya et al.
- Affiliation:
- Department of Surgery · Japan
- Species:
- rodent
Abstract
BACKGROUND: The aim of this study was to investigate gut inflammation and permeability in rats after duodenal-jejunal bypass (DJB) and in rats injected with a glucagon-like peptide-1 (GLP-1) receptor analog. METHODS: Twelve male 16-week-old obese diabetic rats were divided into three groups: the DJB group, the sham group, and the group injected daily with a GLP-1 receptor agonist (liraglutide). Gut inflammation and the expression of tight junction protein (claudin-1) were analyzed in the three groups at 8 weeks after surgery. RESULTS: The DJB group showed significantly lower levels of gut inflammatory cytokines than the liraglutide group. Claudin-1 showed stronger intensity on immunofluorescent staining in the DJB group than that in the liraglutide group. CONCLUSIONS: In summary, DJB surgery might maintain gut permeability via suppression of gut inflammation.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/31209833/